Indication
Randomized
1 clinical trial
2 products
1 drug
Clinical trial
Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease:a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clicnial TrialStatus: Recruiting, Estimated PCD: 2024-03-01
Product
Yangxue QingnaoProduct
Yangxue Qingnao pillsDrug
Varlilumab